US Stock MarketDetailed Quotes
IKT Inhibikase Therapeutics
- 1.5401
- +0.1701+12.42%
Trading Apr 23 11:38 ET
9.97MMarket Cap-431P/E (TTM)
1.6000High1.4400Low53.10KVolume1.4400Open1.3700Pre Close81.92KTurnover0.95%Turnover RatioLossP/E (Static)6.48MShares4.351252wk High0.91P/B8.58MFloat Cap0.790052wk Low--Dividend TTM5.57MShs Float70.8000Historical High--Div YieldTTM11.68%Amplitude0.7900Historical Low1.5420Avg Price1Lot Size
Inhibikase Therapeutics Stock Forum
Sign in to post a comment
Make a note!
$Inhibikase Therapeutics(IKT.US$ Inhibikase Therapeutics - Upon Completion of Double-Blinded Phase of 201 Trial, We Expect to Request an End of Phase 2 Meeting With FDA by End of 2024
6
Update
$Inhibikase Therapeutics(IKT.US$ Inhibikase Therapeutics Announces Apr. 5 Pre-IND Meeting With FDA For IkT-001Pro In Pulmonary Arterial Hypertension
Benzinga· 3 mins ago
Benzinga· 3 mins ago
Update
$Inhibikase Therapeutics(IKT.US$ Inhibikase Reports Preliminary Outcomes Of Pre-NDA Meeting With FDA On Pathway For Approval For IkT-001Pro In Blood And Gastrointestinal Cancers; Says Given Specific Guidance On Manufacturing Requirements Necessary To Complete NDA
1
1
Update
$Inhibikase Therapeutics(IKT.US$ Inhibikase Therapeutics Announces Publication Highlighting Results From Its Phase 1 Studies With Risvodetinib
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Jaguar8 : Love this!
TrytosaveabitOP Jaguar8: Yup yup! I kinda dig it as well!
taijahmed75 TrytosaveabitOP: do you know any reason for the big fall today? Such a good stock….
TrytosaveabitOP taijahmed75: Im guessing it because they said to shareholders Friday there is a big concern whether they will have enough money to continue
taijahmed75 TrytosaveabitOP: Oh ok, thank you
View more comments...